INOVIO PHARMACEUTICALS INC (INOXXXX)
Institutional ownership reported to the SEC as of Q1 2024, across 22 quarters.
3
Reporting holders
$143.6K
Reported value
0.0%
Held as options
-93
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Prime Capital Investment Advisors, LLC | $141.2K | 10,172 | 0.00% | 5q | -92.2%-$1.7M |
| IFP Advisors, Inc | $2.4K | 175 | 0.00% | 17q | -76.7%-$8.0K |
| Sachetta, LLC | $2 | 3 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 3 | $143.6K | 10,350 | 1 | 0 | 2 | 0.0% |
| Q4 2023 | 96 | $19.8M | 38,163,556 | 8 | 17 | 26 | 1.3% |
| Q3 2023 | 114 | $19.5M | 49,674,577 | 11 | 21 | 39 | 0.9% |
| Q2 2023 | 121 | $29.5M | 65,570,958 | 18 | 23 | 41 | 0.7% |
| Q1 2023 | 146 | $94.8M | 115,009,496 | 20 | 36 | 37 | 0.6% |
| Q4 2022 | 145 | $169.9M | 107,363,848 | 31 | 36 | 35 | 1.4% |
| Q3 2022 | 162 | $203.5M | 116,034,899 | 21 | 53 | 36 | 1.6% |
| Q2 2022 | 159 | $199.9M | 113,381,176 | 14 | 63 | 33 | 1.8% |
| Q1 2022 | 181 | $337.1M | 92,049,371 | 21 | 48 | 53 | 2.0% |
| Q4 2021 | 195 | $473.2M | 88,150,635 | 20 | 61 | 58 | 7.0% |
| Q3 2021 | 205 | $600.8M | 77,499,042 | 26 | 56 | 56 | 7.6% |
| Q2 2021 | 210 | $736.6M | 73,700,735 | 38 | 67 | 48 | 7.3% |
| Q1 2021 | 214 | $758.9M | 74,797,649 | 33 | 86 | 53 | 8.6% |
| Q4 2020 | 223 | $695.3M | 66,608,461 | 42 | 71 | 55 | 15.2% |
| Q3 2020 | 219 | $886.2M | 62,380,538 | 48 | 87 | 47 | 18.3% |
| Q2 2020 | 223 | $1.9B | 56,616,779 | 98 | 70 | 32 | 20.1% |
| Q1 2020 | 157 | $387.0M | 46,739,196 | 67 | 43 | 29 | 10.2% |
| Q4 2019 | 105 | $164.9M | 49,790,404 | 12 | 33 | 27 | 0.4% |
| Q3 2019 | 114 | $95.3M | 46,379,456 | 6 | 33 | 30 | 0.1% |
| Q2 2019 | 124 | $135.6M | 45,905,639 | 22 | 34 | 27 | 0.4% |
| Q1 2019 | 123 | $173.4M | 46,326,576 | 13 | 47 | 28 | 0.3% |
| Q4 2018 | 120 | $147.3M | 36,633,966 | 2 | 0 | 4 | 0.5% |